Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting microRNAs as key modulators of tumor immune response.
Paladini L, Fabris L, Bottai G, Raschioni C, Calin GA, Santarpia L. Paladini L, et al. Among authors: raschioni c. J Exp Clin Cancer Res. 2016 Jun 27;35:103. doi: 10.1186/s13046-016-0375-2. J Exp Clin Cancer Res. 2016. PMID: 27349385 Free PMC article. Review.
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients.
Bottai G, Raschioni C, Székely B, Di Tommaso L, Szász AM, Losurdo A, Győrffy B, Ács B, Torrisi R, Karachaliou N, Tőkés T, Caruso M, Kulka J, Roncalli M, Santoro A, Mantovani A, Rosell R, Reis-Filho JS, Santarpia L. Bottai G, et al. Among authors: raschioni c. NPJ Breast Cancer. 2016 Nov 2;2:16033. doi: 10.1038/npjbcancer.2016.33. eCollection 2016. NPJ Breast Cancer. 2016. PMID: 28721387 Free PMC article.
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells.
Gentilini A, Caligiuri A, Raggi C, Rombouts K, Pinzani M, Lori G, Correnti M, Invernizzi P, Rovida E, Navari N, Di Matteo S, Alvaro D, Banales JM, Rodrigues P, Raschioni C, Donadon M, Di Tommaso L, Marra F. Gentilini A, et al. Among authors: raschioni c. Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2246-2256. doi: 10.1016/j.bbadis.2019.04.020. Epub 2019 May 3. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 31059778 Free article.
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.
Personeni N, Rimassa L, Verusio C, Barni S, Rubino L, Bozzarelli S, Villa E, Carnaghi C, Tronconi MC, Gerardi C, Galli F, Floriani I, Destro A, Raschioni C, Labianca R, Santoro A. Personeni N, et al. Among authors: raschioni c. Clin Colorectal Cancer. 2015 Sep;14(3):162-9. doi: 10.1016/j.clcc.2015.02.006. Epub 2015 Mar 6. Clin Colorectal Cancer. 2015. PMID: 25861836 Clinical Trial.